Cargando…
Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
BACKGROUND: Direct-acing antiviral agents are highly efficient treatment options for chronic hepatitis C virus (HCV) infection after renal allograft transplantation. Treatment options for patients with impaired graft function remain limited. Therefore, we assessed the effectiveness and safety of gra...
Autores principales: | Eisenberger, Ute, Friebus-Kardash, Justa, Guberina, Hana, Kribben, Andreas, Witzke, Oliver, Willuweit, Katharina, Gerken, Guido, Herzer, Kerstin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324915/ https://www.ncbi.nlm.nih.gov/pubmed/30656217 http://dx.doi.org/10.1097/TXD.0000000000000860 |
Ejemplares similares
-
GNB3 c.825C>T (rs5443) Polymorphism and Risk of Acute Cardiovascular Events after Renal Allograft Transplant
por: Peitz, Tobias, et al.
Publicado: (2022) -
Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA
por: Xie, Wen Yan, et al.
Publicado: (2021) -
Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection
por: Koslik, Marius Andreas, et al.
Publicado: (2022) -
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016) -
Magnetic Resonance Imaging for Evaluation of Interstitial Fibrosis in Kidney Allografts
por: Beck-Tölly, Andrea, et al.
Publicado: (2020)